Hikma Pharmaceuticals Plc develops, manufactures and markets both branded and non-branded generic and in-licensed products. Hikma operates in three business segments: Branded, Injectables and Generics in the Middle East and North Africa. The Branded segment focuses on the MENA region. It develops, manufactures, and markets branded generics and a portfolio of in-licensed products, many of which are still patent protected. The Generics segment entirely focuses on the U.S. market for oral generics. The Injectables segment manufactures generic injectables. The company was founded by Samih Darwazah in 1978 and is headquartered in London, the United Kingdom.